A New Application for Urethral Strictures: Tacrolimus-Eluting Stent

Abstract

Get full access to this article

View all access options for this article.

References

Kotsar

, Isotalo

, Uurto

et al. Urethral in situ biocompatibility of new drug-eluting biodegradable stents: An experimental study in the rabbit. BJU Int, 2009; 103:1132–1135.

, Zhang

et al. Biodegradable urethral stents seeded with autologous urethral epithelial cells in the treatment of post-traumatic urethral stricture: A feasibility study in a rabbit model. BJU Int, 2009; 104:263–268.

Mikkonen

, Uurto

, Isotalo

et al. Drug-eluting bioabsorbable stents—An in vitro study. Acta Biomater, 2009; 5:2894–2900.

Kotsar

, Nieminen

, Isotalo

et al. Biocompatibility of new drug-eluting biodegradable urethral stent materials. Urology, 2010; 75:229–234.

Aggarwal

, Tsao

, Yeung

, Carter

. Stent-based immunosuppressive therapies for the prevention of restenosis. Cardiovasc Radiat Med, 2003; 4:98–107.

Hamada

, Miyata

, Eto

, Shirasawa

, Akasaki

, Nagaki

, Tei

. Tacrolimus-eluting stent inhibits neointimal hyperplasia via calcineurin/NFAT signaling in porcine coronary artery model. Atherosclerosis, 2010; 208:97–103.

Ebert

, Vogt

, Rösch

. Topical therapy of balanitis xerotica obliterans in childhood. Long-term clinical results and an overview. Urol A, 2007; 46:1682–1686.